Patent · US Active

(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases

US11400097B2 · kind B2 · utility

2Cited by
13References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 13, 2020
Grant dateAug 2, 2022
Priority date—
Expiry dateFeb 13, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N9/1205
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are (alpha-substituted aralkylamino or heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, e.g., a compound of Formula I, and their pharmaceutical compositions, preparation, and use as agents or drugs for treating proliferative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.